Aurisco has been deeply involved in the pharmaceutical industry for more than 20 years and commits itself to continuous technological innovation. Today the company is playing a leading role in China in the field of complex synthesis, synthetic biology, photochemistry etc. And has become a long-term partner of the well-known pharmaceutical companies worldwide
On May 12, 2025, Luiz Inácio Lula da Silva, President of the Federative Republic of Brazil, met with Peng Zhien, Chairman of Aurisco in Beijing.
East China Normal University and Aurisco Pharmaceutical Co., Ltd. jointly inaugurated AI-Driven Oligonucleotide Drugs Discovery Laboratory. The signing and inauguration ceremony of the AI-Driven Oligonucleotide Drugs Discovery Joint Laboratory was held at East China Normal University's Putuo Campus.
Aurisco achieved a score of 78 in the 2024 EcoVadis Corporate Social Responsibility Rating and was awarded a GOLD medal by EcoVadis.
4
Manufacturing Facilities5
R & D Centers260+
Scientists400+
Partnerships1700+
Staff members
Follow Aoruite WeChat official account
We use Cooke to allow the normal operation of our website, personalize the design of content and advertisements, provide social media functions and analyze traffic. We also share information about your use of our website with social media, advertising and analysis partners.
